Radiopharm Theranostics Ltd (RAD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Sales | 3,633 | 299 | 292 | 9 |
| Cost of Goods | 3,594 | N/A | N/A | N/A |
| Gross Profit | 39 | 299 | 292 | 9 |
| Operating Expenses | 34,680 | 36,920 | 34,800 | 19,925 |
| Operating Income | -34,641 | -36,621 | -34,508 | -19,916 |
| Interest Expense | 65 | 643 | 86 | 9,350 |
| Other Income | -3,533 | -10,589 | 21 | -1,028 |
| Pre-tax Income | -38,239 | -47,853 | -34,573 | -30,295 |
| Income Tax | 103 | 96 | 38 | 44 |
| Net Income Continuous | -38,342 | -47,949 | -34,611 | -30,339 |
| Net Income | $-38,342 | $-47,949 | $-34,611 | $-30,339 |
| EPS Basic Total Ops | -0.02 | -0.12 | -0.11 | -0.15 |
| EPS Basic Continuous Ops | -0.02 | -0.12 | -0.11 | -0.15 |
| EPS Diluted Total Ops | -0.02 | -0.12 | -0.11 | -0.15 |
| EPS Diluted Continuous Ops | -0.02 | -0.12 | -0.11 | -0.15 |
| EBITDA(a) | $-38,167 | $-44,084 | $-31,191 | $-17,963 |